Related Experiment Video
Updated: Jun 27, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents
Nagarapu Srinivas1, Shraddha Palne, Nishi
1Medicinal and Process Chemistry Division, Central Drug Research Institute, M.G. Marg, Lucknow, UP 226001, India.
Abstract:
Thirteen novel aryloxy cyclohexane-based mono and bis imidazoles were synthesized and evaluated in vitro as antileishmanials against Leishmania donovani and cytotoxicity assessed. These compounds were better than the existing drugs, sodium stibogluconate and pentamidine in respect to IC(50) and SI values. Promising compounds were tested further in vivo. Among all, the bis methylimidazole with 2-fluoro, 4-nitro aryloxy group (9) exhibited significant in vivo inhibition of 77.9%, thus providing new structural lead for antileishmanials.
More Related Videos
Related Concept Videos
Antiprotozoal Agents
Anthelminthic Agents
Leishmaniasis
Antifungal Agents
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Antiviral Nucleoside Inhibitors

